Non-Thermal Radio Frequency Stimulation of Tubulin Polymerization in Vitro: A Potential Therapy for Cancer Treatment

Download Download as PDF (Size:5939KB)  HTML   XML  PP. 147-168  
DOI: 10.4236/ojbiphy.2014.44015    3,538 Downloads   6,014 Views   Citations

ABSTRACT

The use of radio frequency energy is an established technology for certain oncology therapies. Direct inputs of radio frequency (RF) energy as thermal energy are applied to ablate tumors or catalyze secondary reactions in adjunct treatments against certain tumor types. Yet, other applications are being developed which take advantage of properties of RFs that impinge on biological proteins and cells without thermal effects. Here we report a proof-of-concept application of specific, digitally encoded, low power (non-thermal) radio frequency energy in an in vitro preparation of a tubulin polymerization assay. The radio frequency energy signal, designated M2(3), was applied to the tubulin polymerization assay samples during spectrophotometric measurements to assess the effectiveness for enhancing tubulin polymerization. A commercially available taxane (paclitaxel) that promotes tubulin polymerization was used as a control to assess the effectiveness of the M2(3) radio frequency energy signal on tubulin polymerization rates. A low power, specific, digital radio frequency energy signal is capable of promoting tubulin polymerization as effectively as a commercially available taxane.

Cite this paper

Butters, J. , Figueroa, X. and Butters, B. (2014) Non-Thermal Radio Frequency Stimulation of Tubulin Polymerization in Vitro: A Potential Therapy for Cancer Treatment. Open Journal of Biophysics, 4, 147-168. doi: 10.4236/ojbiphy.2014.44015.

References

[1] Jordan, M.A. and Wilson, L. (2004) Microtubules as a Target for Anticancer Drugs. Nature Reviews Cancer, 4, 253-265.
http://dx.doi.org/10.1038/nrc1317
[2] Agrawal, N.R., Ganapathi, R. and Mekhail, T. (2003) Tubulin Interacting Agents: Novel Taxanes and Epothilones. Current Oncology Reports, 5, 89-98.
http://dx.doi.org/10.1007/s11912-003-0095-6
[3] Wang, T.H., Wang, H.S. and Soong, Y.K. (2000) Paclitaxel-Induced Cell Death: Where the Cell Cycle and Apoptosis Come Together. Cancer, 88, 2619-2628.
http://dx.doi.org/10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J
[4] Verweij, J., Clavel, M. and Chevalier, B. (1994) Paclitaxel (Taxol) and docetaxel (Taxotere): Not Simply Two of a Kind. Annals of Oncology, 5, 495-505.
[5] Lammers, T., et al. (2012) Drug Targeting to Tumors: Principles, Pitfalls and (Pre-) Clinical Progress. Journal of Controlled Release, 161, 175-187.
http://dx.doi.org/10.1016/j.jconrel.2011.09.063
[6] Corti, A., et al. (2012) Targeted Drug Delivery and Penetration into Solid Tumors. Medicinal Research Reviews, 32, 1078-1091.
http://dx.doi.org/10.1002/med.20238
[7] Deeken, J.F. and Loscher, W. (2007) The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses. Clinical Cancer Research, 13, 1663-1674.
http://dx.doi.org/10.1158/1078-0432.CCR-06-2854
[8] Orr, G.A., et al. (2003) Mechanisms of Taxol Resistance Related to Microtubules. Oncogene, 22, 7280-7295.
http://dx.doi.org/10.1038/sj.onc.1206934
[9] Yusuf, R.Z., et al. (2003) Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation. Current Cancer Drug Targets, 3, 1-19.
http://dx.doi.org/10.2174/1568009033333754
[10] Kavallaris, M., Annereau, J.P. and Barret, J.M. (2008) Potential Mechanisms of Resistance to Microtubule Inhibitors. Seminars in Oncology, 35, S22-S27.
http://dx.doi.org/10.1053/j.seminoncol.2008.01.006
[11] Kinsella, A.R., Smith, D. and Pickard, M. (1997) Resistance to Chemotherapeutic Antimetabolites: A Function of Salvage Pathway Involvement and Cellular Response to DNA Damage. British Journal of Cancer, 75, 935-945.
http://dx.doi.org/10.1038/bjc.1997.164
[12] Zhou, X.J. and Rahmani, R. (1992) Preclinical and Clinical Pharmacology of Vinca Alkaloids. Drugs, 44, 1-16.
http://dx.doi.org/10.2165/00003495-199200444-00002
[13] Robitaille, P.M., Kangarlu, A. and Abduljalil, A.M. (1999) RF Penetration in Ultra High Field MRI: Challenges in Visualizing Details within the Center of the Human Brain. Journal of Computer Assisted Tomography, 23, 845-849.
http://dx.doi.org/10.1097/00004728-199911000-00006
[14] Roschmann, P. (1987) Radiofrequency Penetration and Absorption in the Human Body: Limitations to High-Field Whole-Body Nuclear Magnetic Resonance Imaging. Medical Physics, 14, 922-931.
http://dx.doi.org/10.1118/1.595995
[15] Bottomley, P.A. and Andrew, E.R. (1978) RF Magnetic Field Penetration, Phase Shift and Power Dissipation in Biological Tissue: Implications for NMR Imaging. Physics in Medicine and Biology, 23, 630-643.
[16] Conzo, G., Sciascia, V., Palazzo, A., Stanzione, F., Pietra, C.D., Insabato, L., et al. (2013) Radiofrequency-Assisted Partial Nephrectomy for Metanephric Adenoma: A Case Report and Literature Review. Surgical Innovation, 20, 55-58.
http://dx.doi.org/10.1177/1553350612442792
[17] Schutt, D.J. and Haemmerich, D. (2008) Tumor Ablation at Low Frequencies for Preferential Tumor Heating: Initial Ex-Vivo Tissue Studies. Proceedings of 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS 2008, Vancouver, 20-25 August 2008, 238-241.
[18] Belfiore, G., Tedeschi, E., Ronza, F.M., Belfiore, M.P., Volpe, T.D., Zeppetella, G., et al. (2008) Radiofrequency Ablation of Bone Metastases Induces Long-Lasting Palliation in Patients with Untreatable Cancer. Singapore Medical Journal, 49, 565-570.
[19] Schmidt, C. (2008) The Kanzius Machine: A New Cancer Treatment Idea from an Unexpected Source. Journal of the National Cancer Institute, 100, 985-986.
http://dx.doi.org/10.1093/jnci/djn246
[20] Chen, H., Liu, R., Liu, J. and Tang, J. (2012) Growth Inhibition of Malignant Melanoma by Intermediate Frequency Alternating Electric Fields, and the Underlying Mechanisms. Journal of International Medical Research, 40, 85-94.
http://dx.doi.org/10.1177/147323001204000109
[21] Mrugala, M.M., Adair, J.E. and Kiem, H.P. (2012) Outside the Box—Novel Therapeutic Strategies for Glioblastoma. Cancer Journal, 18, 51-58.
http://dx.doi.org/10.1097/PPO.0b013e318243f785
[22] Pless, M. and Weinberg, U. (2011) Tumor Treating Fields: Concept, Evidence and Future. Expert Opinion on Investigational Drugs, 20, 1099-1106.
http://dx.doi.org/10.1517/13543784.2011.583236
[23] Kirson, E.D., Giladi, M., Gurvich, Z., Itzhaki, A., Mordechovich, D., Schneiderman, R.S., et al. (2009) Alternating Electric Fields (TTFields) Inhibit Metastatic Spread of Solid Tumors to the Lungs. Clinical & Experimental Metastasis, 26, 633-640.
http://dx.doi.org/10.1007/s10585-009-9262-y
[24] Schroeder, T., Viglianti, B.L. and Dewhirst, M.W. (2008) Low-Intensity Alternating Electric Fields: A Potentially Safe and Effective Treatment of Cancer? Onkologie, 31, 357-358.
http://dx.doi.org/10.1159/000140601
[25] Kirson, E.D., Dbaly, V., Tovarys, F., Vymazal, J., Soustiel, J.F., Itzhaki, A., et al. (2007) Alternating Electric Fields Arrest Cell Proliferation in Animal Tumor Models and Human Brain Tumors. Proceedings of the National Academy of Sciences of the United States of America, 104, 10152-10157.
http://dx.doi.org/10.1073/pnas.0702916104
[26] Gutin, P.H. and Wong, E.T. (2012) Noninvasive Application of Alternating Electric Fields in Glioblastoma: A Fourth Cancer Treatment Modality. American Society of Clinical Oncology Educational Book, 32, 126-131.
[27] Berg, H., Günther, B., Hilger, I., Radeva, M., Traitcheva, N. and Wollweber, L. (2010) Bioelectromagnetic Field Effects on Cancer Cells and Mice Tumors. Electromagnetic Biology and Medicine, 29, 132-143.
http://dx.doi.org/10.3109/15368371003776725
[28] Beneduci, A., Chidichimo, G., De Rose, R., Filippelli, L., Straface, S.V. and Venuta, S. (2005) Frequency and Irradiation Time-Dependant Antiproliferative Effect of Low-Power Millimeter Waves on RPMI 7932 Human Melanoma Cell Line. Anticancer Research, 25, 1023-1028.
[29] Beneduci, A., Chidichimo, G., Tripepi, S., Perrotta, E. and Cufone, F. (2007) Antiproliferative Effect of Millimeter Radiation on Human Erythromyeloid Leukemia Cell line K562 in Culture: Ultrastructural- and Metabolic-Induced Changes. Bioelectrochemistry, 70, 214-220.
http://dx.doi.org/10.1016/j.bioelechem.2006.07.008
[30] Barbault, A., Costa, F.P., Bottger, B., Munden, R.F., Bomholt, F., Kuster, N., et al. (2009) Amplitude-Modulated Electromagnetic Fields for the Treatment of Cancer: Discovery of Tumor-Specific Frequencies and Assessment of a Novel Therapeutic Approach. Journal of Experimental & Clinical Cancer Research, 28, 51.
http://dx.doi.org/10.1186/1756-9966-28-51
[31] Zimmerman, J.W., Jimenez, H., Pennison, M.J., Brezovich, I., Morgan, D., Mudry, A., et al. (201) Targeted Treatment of Cancer with Radiofrequency Electromagnetic Fields Amplitude-Modulated at Tumor-Specific Frequencies. Chinese Journal of Cancer, 32, 573-581.
[32] Zimmerman, J.W., Pennison, M.J., Brezovich, I., Yi, N., Yang, C.T., Ramaker, R., et al. (2012) Cancer Cell Proliferation Is Inhibited by Specific Modulation Frequencies. British Journal of Cancer, 106, 307-313.
http://dx.doi.org/10.1038/bjc.2011.523
[33] Crocetti, S., Beyer, C., Schade, G., Egli, M., Frohlich, J. and Franco-Obregón, A. (2013) Low Intensity and Frequency Pulsed Electromagnetic Fields Selectively Impair Breast Cancer Cell Viability. PLoS ONE, 8, e72944.
http://dx.doi.org/10.1371/journal.pone.0072944
[34] Mitra, A. and Sept, D. (2008) Taxol Allosterically Alters the Dynamics of the Tubulin Dimer and Increases the Flexibility of Microtubules. Biophysical Journal, 95, 3252-3258.
http://dx.doi.org/10.1529/biophysj.108.133884
[35] Goodman, R., Lin-Ye, A., Geddis, M.S., Wickramaratne, P.J., Hodge, S.E., Pantazatos, S.P., et al. (2009) Extremely Low Frequency Electromagnetic Fields Activate the ERK Cascade, Increase hsp70 Protein Levels and Promote Regeneration in Planaria. International Journal of Radiation Biology, 85, 851-859.
[36] Blank, M. and Goodman, R. (2009) Electromagnetic Fields Stress Living Cells. Pathophysiology, 16, 71-78.
http://dx.doi.org/10.1016/j.pathophys.2009.01.006
[37] Blank, M. (2005) Do Electromagnetic Fields Interact with Electrons in the Na,K-ATPase? Bioelectromagnetics, 26, 677-683.
http://dx.doi.org/10.1002/bem.20167
[38] Blank, M. and Goodman, R. (2004) Initial Interactions in Electromagnetic Field-Induced Biosynthesis. Journal of Cellular Physiology, 199, 359-363.
http://dx.doi.org/10.1002/jcp.20004
[39] Ríhová, B., Etrych, T., Sírová, M., Tomala, J., Ulbrich, K. and Kovár, M. (2011) Synergistic Effect of EMF-BEMER-Type Pulsed Weak Electromagnetic Field and HPMA-Bound Doxorubicin on Mouse EL4 T-Cell Lymphoma. Journal of Drug Targeting, 19, 890-899.
http://dx.doi.org/10.3109/1061186X.2011.622403
[40] Beneduci, A. (2009) Evaluation of the Potential in Vitro Antiproliferative Effects of Millimeter Waves at Some Therapeutic Frequencies on RPMI 7932 Human Skin Malignant Melanoma Cells. Cell Biochemistry and Biophysics, 55, 25-32.
http://dx.doi.org/10.1007/s12013-009-9053-8
[41] Beneduci, A., Chidichimo, G., Tripepi, S. and Perrotta, E. (2005) Transmission Electron Microscopy Study of the Effects Produced by Wide-Band Low-Power Millimeter Waves on MCF-7 Human Breast Cancer Cells in Culture. Anticancer Research, 25, 1009-1013.
[42] Fedorowski, A., Steciwko, A. and Rabczynski, J. (2004) Low-Frequency Electromagnetic Stimulation May Lead to Regression of Morris Hepatoma in Buffalo Rats. Journal of Alternative and Complementary Medicine, 10, 251-260.
http://dx.doi.org/10.1089/107555304323062248
[43] Chidichimo, G., Beneduci, A., Nicoletta, M., Critelli, M., De Rose, R., Tkatchenko, Y., et al. (2002) Selective Inhibition of Tumoral Cells Growth by Low Power Millimeter Waves. Anticancer Research, 22, 1681-1688.
[44] Ufimtsev, I.S., Luehr, N. and Martinez, T.J. (2011) Charge Transfer and Polarization in Solvated Proteins from Ab Initio Molecular Dynamics. Journal of Physical Chemistry Letters, 2, 1789-1793.
http://dx.doi.org/10.1021/jz200697c
[45] Boxer, S.G. (1990) Mechanisms of Long-Distance Electron Transfer in Proteins: Lessons from Photosynthetic Reaction Centers. Annual Review of Biophysics and Biophysical Chemistry, 19, 267-299.
http://dx.doi.org/10.1146/annurev.bb.19.060190.001411
[46] Kuffel, A. and Zielkiewicz, J. (2013) Properties of Water in the Region between a Tubulin Dimer and a Single Motor Head of Kinesin. Physical Chemistry Chemical Physics, 15, 4527-4537.
http://dx.doi.org/10.1039/c3cp43828g
[47] Blank, M. (2008) Protein and DNA Reactions Stimulated by Electromagnetic Fields. Electromagnetic Biology and Medicine, 27, 3-23.
[48] Davis, A., Martinez, S., Nelson, D. and Middleton, K. (2010) A Tubulin Polymerization Microassay Used to Compare Ligand Efficacy. Methods in Cell Biology, 95, 331-351.
http://dx.doi.org/10.1016/S0091-679X(10)95018-8
[49] Davis, A., Jiang, J.D., Middleton, K.M., Wang, Y., Weisz, I., Ling, Y.H., et al. (1999) Novel Suicide Ligands of Tubulin Arrest Cancer Cells in S-Phase. Neoplasia, 1, 498-507.
http://dx.doi.org/10.1038/sj.neo.7900066
[50] Jiang, J.D., Davis, A.S., Middleton, K., et al. (1998) 3-(Iodoacetamido)-Benzoylurea: A Novel Cancericidal Tubulin Ligand That Inhibits Microtubule Polymerization, Phosphorylates bcl-2, and Induces Apoptosis in Tumor Cells. Cancer Research, 58, 5389-5395.

  
comments powered by Disqus

Copyright © 2017 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.